VIA Disc NP

OTHER4 trials

Sponsors

VIVEX Biologics, Inc.

Conditions

Back PainBack Pain, LowDegenerative Disc DiseaseDisc DegenerationDiscogenic PainLow Back PainLumbar Discogenic Pain

Phase 2

ASCEND: A Clinical Trial to Evaluate the Safety and Effectiveness of VIA Disc NP, a Supplement for Degenerated Intervertebral Discs

Active, not recruitingNCT06615505

VIVEX Biologics, Inc.Degenerative Disc Disease, Disc Degeneration, Lumbar Discogenic Pain

Start: 2024-10-04End: 2027-11-01Updated: 2026-06-16

Unknown Phase

VIA Disc NP Pilot for Patients With Symptomatic Degenerated Discs

Active, not recruitingNCT05201287

VIVEX Biologics, Inc.Degenerative Disc Disease, Disc Degeneration, Low Back Pain

Start: 2021-12-30End: 2024-12-27Updated: 2024-04-29

VIA Disc NP Registry 3.0

Active, not recruitingNCT06345690

VIVEX Biologics, Inc.Back Pain, Back Pain, Low, Discogenic Pain

Start: 2024-02-27End: 2027-01-01Target: 500Updated: 2026-05-12

Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

RecruitingNCT06778447

VIVEX Biologics, Inc.Degenerative Disc Disease, Disc Degeneration, Lumbar Discogenic Pain

Start: 2025-02-17End: 2028-10-01Target: 325Updated: 2026-09-14

Related Papers

Safety and efficacy of intradiscal nucleus pulposus allograft versus sham for lumbar discogenic pain associated with degenerative disc disease: study protocol for a randomized clinical trial.

2026-06-08

Supplemental nucleus pulposus allograft in patients with lumbar discogenic pain: results of a prospective feasibility study.

2025-05-011 citations